Table 1 Antimicrobial activity of extracts obtained from N. sphaerica at concentrations ranging from 128 to 0.25 μg/mL
Microorganisms | MIC/MBC or MFC (μg/mL) | ||||||
|---|---|---|---|---|---|---|---|
BE | CE | CH | Vancomycin | Gentamicin | Clotrimazole | Amphotericin B | |
Bacteria | |||||||
  Staphylococcus aureus ATCC25923 | 16/128 | 64/128 | 128/128 | 0.5/1 | – | – | – |
  Methicillin-resistant S. aureus (MRSA) | 32/128 | 128/128 | 128/128 | 1/2 | – | – | – |
  Escherichia coli ATCC25922 | – | – | – | 0.25/1 | – | – | – |
  Pseudomonas aeruginosa ATCC27853 | – | – | – | 0.25/1 | – | – | – |
Yeast | |||||||
  Candida albicans ATCC90028 | 62/128 | 128/128 | 64/128 | – | – | – | 0.25/1 |
  C. albicans NCPF3153 | 64/128 | 128/128 | 128/128 | – | – | – | 0.125/1 |
  Cryptococcus neoformans ATCC90112 | 64/128 | 128/128 | 128/128 | – | – | – | 0.25/1 |
  C. neoformans ATCC90113 | 128/128 | 128/128 | 128/128 | – | – | – | 0.25/1 |
Filamentous fungi | |||||||
  Microsporum gypseum clinical isolate | – | – | – | – | – | 1/32 | – |
  Talaromyces marneffei clinical isolate | 4/16 | 128/128 | – | – | – | – | 0.25/2 |